Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the study is to assess whether the performance of type 2 quadratus lumborum block produces an improvement in the quality of life of the patient with osteoarthritis of the hip.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

NCT03801265

Hip Osteoarthritis

COMPLETED PHASE4

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

NCT03408483

Total Hip Arthroplasty

COMPLETED PHASE2/PHASE3

Comparison Between Single Shot Ultrasonographic Guided Fascia Iliaca Block and Quadratus Lumborum Block in Hip Arthralgia. Comparative Double Blind Study

NCT04733586

Analgesia

UNKNOWN NA

Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy

NCT02346357

Pain

UNKNOWN NA

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

NCT03744065

Hip Osteoarthritis Pain, Acute Pain, Postoperative +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The quadratus lumborum block is an interfascial block of the posterior wall of the abdomen, initially described for the management of postoperative pain in abdominal surgery due to its suggested effect on the T7-11 roots. The analgesic efficacy of type 1 quadratus lumborum block (QL1) in hip surgery was subsequently published. Regarding chronic pain, QL2 has been successfully performed in posttherniorrhaphy pain or pancreatic cancer.

This quadratus lumborum type 2 or posterior, is performed in the patients with hip joint based on the innervation of the hip and taking the role of thoraco-lumbar fascia in the analgesia of these patients as a reference. The good results obtained in the first 5 patients have led us to evaluate whether this blockade can indeed be an analgesic alternative in patients with coxarthrosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthropathy Chronic Hip Pain Ultrasound Therapy; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

quadratus lumborum

analgesic technique. The evaluation of the patient will consist of 2 stages. The first of these will consist of the evaluation consultation (clinical history, EVN evaluation, WOMAC) and initial treatment (QL2 block). In the second stage, the patient will be followed up with interviews at 3 weeks, 3 and 6 months.

levobupivacaine

Intervention Type DRUG

local anesthetic

ultrasound device

Intervention Type DEVICE

scream

Control

Current analgesia , no QL block apply

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

levobupivacaine

local anesthetic

Intervention Type DRUG

ultrasound device

scream

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

chirocane

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sign informed consent (Annex 2)
* Age 18-85 years
* Cartilage injury (coxarthrosis) hip
* Illness \<1 year of evolution
* Patients with pain after treatment with physical therapy, exercises, NSAIDs.
* EVN\> 5

Exclusion Criteria

* Refusal of the patient
* Allergy to the drugs used
* Contraindication for performing the technique
* Intraarticular treatment in the previous 3 months
* Pregnancy

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No